Silence Therapeutics Plc Share Price

Silence Therapeutics Plc Share Price

NASDAQ: SLN | Mid Cap
$19.73
+$0.03 (0.15%) Last updated on 29 Oct, 2026 | 20:35 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Silence Therapeutics Plc Stock Performance

Open
$19.73
Prev. Close
$19.70
Circuit Range
N/A
Day Range
$19.72 - $19.73
Year Range
$4.20 - $19.85
Volume
10,217
Average Traded
$19.72

Silence Therapeutics Plc Share Price Today

As of 29 October 2026, Silence Therapeutics Plc's share price is $19.73. The stock opened at $19.73, compared to its previous close of $19.70. During today's trading session, Silence Therapeutics Plc's share price traded between $19.72 and $19.73, with an average price of $19.73. Over the past 52 weeks, the stock has recorded a high of $19.85 and a low of $4.20. In terms of performance, Silence Therapeutics Plc's share price has risen by 169.60% over the last six months and is up 176.59% on a year-on-year basis.

Silence Therapeutics Plc Share Price Chart

Line chart of the Silence Therapeutics Plc price trend over the selected period. The price rose overall, ranging from 19.72 to 19.73, ending at 19.73.
$19.72$19.73
L
Show Current Price
H

Silence Therapeutics Plc Stock Fundamentals & Key Indicators

Market Cap
$2.80B
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

About Silence Therapeutics Plc

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Silence Therapeutics Plc Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$11.00
$19.73
+79.98%
Sep 2026
$13.37
$10.96
-18.42%
Aug 2026
$10.43
$13.44
+28.37%
Jul 2026
$11.05
$10.47
-4.73%
Jun 2026
$6.76
$10.99
+59.04%
May 2026
$7.08
$6.91
-5.60%
Apr 2026
$5.86
$7.32
+39.69%
Mar 2026
$5.51
$5.24
-4.38%
Feb 2026
$4.83
$5.48
+13.81%
Jan 2026
$6.14
$4.82
-20.81%
Dec 2025
$6.68
$6.08
-9.25%
Nov 2025
$7.24
$6.70
-6.10%

SLN Share Price FAQs